News Daily News The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score Todd Neale March 10, 2017
News Daily News Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin Todd Neale March 07, 2017
News Conference News CRT 2017 Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy Michael O'Riordan February 20, 2017
Presentation JIM 2017 Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It Presenter: Dominick J. Angiolillo February 10, 2017
News Daily News Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy Michael O'Riordan January 18, 2017
News Daily News Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival Michael O'Riordan December 13, 2016
News Daily News ¿FOP y Migrañas? Un Nuevo Estudio se Centra en los Aneurismas del Tabique Interauricular Shelley Wood December 08, 2016
News Daily News PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms Shelley Wood December 08, 2016
News Daily News With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab Yael L. Maxwell December 06, 2016
News Daily News Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización Yael L. Maxwell December 06, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
Presentation TCT 2016 Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo November 01, 2016
Presentation TCT 2016 Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate November 01, 2016
Presentation TCT 2016 TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR Presenter: Andreas Baumbach, Kurt Huber, Elmir Omerovic October 31, 2016
Presentation TCT 2016 TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry Presenter: Dimitrios Alexopoulos, Laurent Bonello, Usman Baber October 31, 2016
Presentation TCT 2016 Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm Presenter: John A. Bittl, Daniel I. Simon, Patrick W. Serruys October 30, 2016
Presentation TCT 2016 Transitioning Between Cangrelor and Oral P2Y12 Inhibitors: All the Permutations Presenter: Deepak L. Bhatt, Christian W. Hamm, Paul A. Gurbel October 30, 2016
News Daily News Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge Todd Neale October 18, 2016